This opportunity is no longer accepting applications.
grant PAR-22-218

Biology of Bladder Cancer (R01 Clinical Trial Optional)

This grant opportunity invites research applications focused on understanding the biology and mechanisms of bladder cancer. Bladder cancer poses a significant health issue due to its high incidence and recurrence, contributing to a substantial medical burden. Despite recent advances in identifying genetic mutations, the molecular processes behind the initiation and progression of bladder cance…

This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder can…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: July 26, 2022
Open for Submission: July 26, 2022
Submission Deadline: September 7, 2025
Application Window Closes: September 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.